M Arenas

596 total citations
26 papers, 459 citations indexed

About

M Arenas is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, M Arenas has authored 26 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Public Health, Environmental and Occupational Health, 5 papers in Molecular Biology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in M Arenas's work include Acute Lymphoblastic Leukemia research (11 papers), Biochemical and Molecular Research (4 papers) and Adolescent and Pediatric Healthcare (3 papers). M Arenas is often cited by papers focused on Acute Lymphoblastic Leukemia research (11 papers), Biochemical and Molecular Research (4 papers) and Adolescent and Pediatric Healthcare (3 papers). M Arenas collaborates with scholars based in United Kingdom, Spain and Australia. M Arenas's co-authors include Anthony M. Marinaki, Jeremy Sanderson, Azhar Ansari, J. A. Duley, Cathryn M. Lewis, Melissa Smith, Lynette D. Fairbanks, James O. Lindsay, Simon Greenfield and Kristen Gilshenan and has published in prestigious journals such as Gastroenterology, Gut and British Journal of Dermatology.

In The Last Decade

M Arenas

25 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Arenas United Kingdom 11 255 174 95 85 76 26 459
Emilia Escuredo United Kingdom 5 247 1.0× 80 0.5× 112 1.2× 57 0.7× 101 1.3× 9 400
Nicolas Ferrari France 6 332 1.3× 269 1.5× 95 1.0× 110 1.3× 112 1.5× 10 630
S. LATOUR Canada 3 249 1.0× 168 1.0× 48 0.5× 77 0.9× 24 0.3× 3 331
Peer de Graaf Netherlands 10 293 1.1× 186 1.1× 60 0.6× 124 1.5× 30 0.4× 13 496
Scott A. Hande United States 6 319 1.3× 274 1.6× 52 0.5× 137 1.6× 18 0.2× 6 436
Carmelo Cuffari United States 7 267 1.0× 237 1.4× 55 0.6× 112 1.3× 14 0.2× 11 412
Gülsün Karasu Türkiye 12 74 0.3× 58 0.3× 109 1.1× 58 0.7× 32 0.4× 47 403
Bendik Lund Norway 14 380 1.5× 31 0.2× 333 3.5× 40 0.5× 92 1.2× 29 660
Julian Katz United States 12 257 1.0× 58 0.3× 214 2.3× 70 0.8× 99 1.3× 18 588
Gertjan J. A. Driessen Netherlands 14 126 0.5× 134 0.8× 45 0.5× 156 1.8× 154 2.0× 26 590

Countries citing papers authored by M Arenas

Since Specialization
Citations

This map shows the geographic impact of M Arenas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Arenas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Arenas more than expected).

Fields of papers citing papers by M Arenas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Arenas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Arenas. The network helps show where M Arenas may publish in the future.

Co-authorship network of co-authors of M Arenas

This figure shows the co-authorship network connecting the top 25 collaborators of M Arenas. A scholar is included among the top collaborators of M Arenas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Arenas. M Arenas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Melissa, Paul Blaker, Chandan Patel, et al.. (2012). The impact of introducing thioguanine nucleotide monitoring into an inflammatory bowel disease clinic. International Journal of Clinical Practice. 67(2). 161–169. 46 indexed citations
2.
Blaker, Paul, M Arenas, L. D. Fairbanks, et al.. (2011). A biochemical mechanism for the role of allopurinol in TMPT inhibition. Gut. 60(Suppl 1). A132.2–A133. 3 indexed citations
3.
Corrigan, Adam, et al.. (2011). HPRT Deficiency: Identification of Twenty-Four Novel Variants Including an Unusual Deep Intronic Mutation. Nucleosides Nucleotides & Nucleic Acids. 30(12). 1260–1265. 12 indexed citations
4.
Smith, Melissa, Anthony M. Marinaki, M Arenas, et al.. (2009). Novel pharmacogenetic markers for treatment outcome in azathioprine‐treated inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 30(4). 375–384. 71 indexed citations
5.
Arenas, M, et al.. (2009). An unusual genetic variant in the MOCS1 gene leads to complete missplicing of an alternatively spliced exon in a patient with molybdenum cofactor deficiency. Journal of Inherited Metabolic Disease. 32(4). 560–569. 21 indexed citations
6.
Ansari, Azhar, M Arenas, Simon Greenfield, et al.. (2008). Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 28(8). 973–983. 135 indexed citations
7.
Baburajan, Bijay, M Arenas, Natalie J. Prescott, et al.. (2007). The pharmacogenetics of folate and purine metabolic pathways in methotrexate therapy of inflammatory bowel disease.. Gut. 56. 1 indexed citations
8.
Baburajan, Bijay, Natalie J. Prescott, K Herrlinger, et al.. (2007). HLA-G 14BP insertion-deletion polymorphism influences response to methotrexate in inflammatory bowel disease.. Gut. 56. 1 indexed citations
9.
Clemente, Susana, et al.. (2007). Administración de antiinfecciosos por vía inhalatoria. Farmacia Hospitalaria. 31(2). 112–119. 8 indexed citations
10.
Fernández-Polo, Aurora, et al.. (2007). Osmolalidad de las formas farmacéuticas orales líquidas en un hospital para su aplicación en neonatos. Farmacia Hospitalaria. 31(5). 311–314. 12 indexed citations
11.
Campalani, Emanuela, M Arenas, Anthony M. Marinaki, Juliet N. Barker, & Catherine Smith. (2006). Polymorphisms in folate, pyrimidine and purine metabolism have an impact on methotrexate efficacy and toxicity in psoriasis.. British Journal of Dermatology. 155. 1–1. 2 indexed citations
12.
Campalani, Emanuela, et al.. (2006). A pharmacogenetic study of methotrexate and polymorphisms of folate and pyrimidine metabolism in psoriasis.. British Journal of Dermatology. 154(1).
13.
Zamora, Núria Padullés, et al.. (2006). Interacción farmacocinética entre ácido valproico y meropenem. Anales de Pediatría. 64(1). 93–95. 7 indexed citations
14.
Arenas, M, et al.. (2005). Utilización de medicamentos en una UCI neonatal: estudio prospectivo. Farmacia Hospitalaria. 29(1). 26–29. 19 indexed citations
15.
Clemente, Susana, et al.. (2005). Dosificación de fármacos en administración cerebroespinal. Farmacia Hospitalaria. 29(3). 185–190. 4 indexed citations
16.
Ansari, Azhar, M Arenas, Donald G. Morris, et al.. (2004). Pharmacogenetic profiling in azathioprine treatment: TPMT, ITPA, and MTHFR polymorphisms and toxicity. Gastroenterology. 53(4). 1 indexed citations
17.
Ansari, Azhar, M Arenas, Daniel Morris, et al.. (2004). Thiopurine methyl transferase activity predicts both toxicity and clinical response to azathioprine in inflammatory bowel disease: The London IBD forum prospective study. Gut. 53(4). 32. 5 indexed citations
18.
Marinaki, Anthony M., J. A. Duley, M Arenas, et al.. (2004). Mutation in theITPAGene Predicts Intolerance to Azathioprine. Nucleosides Nucleotides & Nucleic Acids. 23(8-9). 1393–1397. 55 indexed citations
19.
Arenas, M, et al.. (2004). Pharmacogenetic profiling in azathioprine therapy: The role of TPMT, ITPA and MTHFR polymorphisms in drug toxicity. Gastroenterology. 126(4). 1 indexed citations
20.
Arenas, M, et al.. (1992). Selective inhibition of granulopoiesis with severe neutropenia in systemic lupus erythematosus. Arthritis & Rheumatism. 35(8). 979–980. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emilia Escuredo Breakdown of academic impact, for papers by Nicolas Ferrari Breakdown of academic impact, for papers by S. LATOUR Breakdown of academic impact, for papers by Peer de Graaf Breakdown of academic impact, for papers by Scott A. Hande Breakdown of academic impact, for papers by Carmelo Cuffari Breakdown of academic impact, for papers by Gülsün Karasu Breakdown of academic impact, for papers by Bendik Lund Breakdown of academic impact, for papers by Julian Katz Breakdown of academic impact, for papers by Gertjan J. A. Driessen
Rankless by CCL
2026